18 résultats avec le mot-clé: 'microrna biomarkers regulators b cell chronic lymphocytic leukemia'
To identify miRNA with potential clinical applications, we initially profiled miRNA spectra from nine pooled samples including pooled healthy control, six pooled CLL samples based
N/A
Abbreviations: ADCC, antibody-dependent cell-mediated cytotoxicity; AML, acute myeloid leukemia; B-CLL, B-cell chronic lymphocytic leukemia; B-NHL, B-cell non-Hodgkin’s lymphoma;
N/A
TITLE: Impact of B-cell Chronic Lymphocytic Leukemia cell components in post- therapeutic relapses : from leukemic chemoresistant Side Population to immune cells. B-cell
N/A
Patients and methods: In the multicenter HD8 study of the German Hodgkin Study Group, 1204 patients with early-stage unfavorable HL were randomized to receive four cycles
N/A
Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD20 monoclonal antibody
N/A
Entospletinib monotherapy in patients with relapsed or refractory chronic lymphocytic leukemia previously treated with B-cell receptor inhibitors: results of a phase 2
N/A
CD47 Agonist Peptides Induce Programmed Cell Death in Refractory Chronic Lymphocytic Leukemia B Cells via PLCγ1 Activation: Evidence from Mice and Humans... Susin
N/A
Intermittant two-hour intravenous infusions of 2-chlorodeoxyadenosine in the treatment of 110 patients with refractory or previously untreated B-cell chronic lymphocytic
N/A
MDS, myelodysplastic syndrome; AML, acute myeloid leukemia; CLL, chronic lymphocytic leukemia; MM, multiple myeloma; CML, chronic myelogenous leukemia; ALL, acute
N/A
Background: Deletions at 13q14.3 are common in chronic lymphocytic leukemia and are also present in diffuse large B-cell lymphomas (DLBCL) but never in immunodeficiency-related
N/A
5–8 Recent studies described 48 patients with renal involvement in a large cohort of patients with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis, and 35 patients
N/A
The NTSR2 – TrkB interaction is strengthened upon BDNF stimulation, and triggers pro-survival pathways via phosphorylation of NTSR2, resulting in activation of the
N/A
Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial.. Rossi D, Gerber B,
N/A
Although these authors did not test the role of HLA mismatch in B-CLL resistance, and we have not formally tested this potential evasion mechanism, our data comparing
N/A
Unlike renal involvement in monoclonal gammapathies, the description of kidney diseases associated with CLL/SLL is currently limited to case reports and small series of
N/A
Abstract-The peripheral mononuclear cells from 23 normal individuals and the purified B cells from 38 patients with chronic lymphocytic leukemia (CLL) were
N/A
Pour un coût de mesure fixé à 1, nous avons observé un nombre moyen de mesure de 0.17 (ce qui équivaut à un lien mesuré tout les 6 pas de temps) pour un délai supplémentaire
N/A
Results: In this work we have analyzed the relative abundance of the aberrant spliced forms Caspase-9b and PP2Ac α2 in several cell lines and chronic lymphocytic leukemia patients
N/A